Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wernicke's encephalopathy--causes to consider

N Heye1, K Terstegge, C Sirtl

  • 1Neurological Clinic, St.-Josef Hospital, Ruhr-Universität, Bochum, Germany.

Intensive Care Medicine
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.

Multiple sclerosis and related disorders·2023
Same author

A bridge over troubled waters: Anti-inflammatory therapy for patients with refractory obstetric antiphospholipid syndrome?

Thrombosis research·2021
Same author

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.

Seminars in arthritis and rheumatism·2020
Same author

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Using hydroxychloroquine and protecting the retina.

Lupus·2018
Same author

Disability in progressive MS is associated with T2 lesion changes.

Multiple sclerosis and related disorders·2018
Same journal

Publisher Correction: Current knowledge and challenges of sepsis-associated encephalopathy.

Intensive care medicine·2026
Same journal

Prehospital airway and ventilatory management: a collaborative and narrative review.

Intensive care medicine·2026
Same journal

Rapid coma with bilateral basal ganglia involvement.

Intensive care medicine·2026
Same journal

From size to function: moving beyond body mass index to frailty and central adiposity phenotypes.

Intensive care medicine·2026
Same journal

Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial.

Intensive care medicine·2026
Same journal

Hypercalcemia in intensive care unit: pathophysiological mechanisms and clinical implications.

Intensive care medicine·2026
See all related articles

Wernicke

Area of Science:

  • Neurology
  • Nutritional Science

Background:

  • Wernicke's encephalopathy (WE) is a neurological disorder caused by thiamine (vitamin B1) deficiency.
  • Clinical presentation typically includes ocular abnormalities, ataxia, and disturbances of consciousness.

Observation:

  • This report details three patients with Wernicke's encephalopathy.
  • Two patients received insufficient thiamine substitution, with one experiencing symptom resolution after adequate treatment.
  • The second patient's acute WE was a terminal event amidst other critical conditions.

Findings:

  • One patient developed WE despite adequate thiamine substitution, possibly due to hereditary factors.
  • WE can be a critical complication in patients with alcoholism, malnutrition, malabsorption, cancer, inflammatory conditions, severe illnesses, and those receiving parenteral hyperalimentation.

Related Experiment Videos

Implications:

  • Prompt thiamine substitution (at least 100 mg/day IV or IM) is crucial for preventing and treating Wernicke's encephalopathy.
  • Clinicians should maintain a high index of suspicion for thiamine deficiency in at-risk populations.
  • Understanding potential hereditary influences on WE development may inform personalized treatment strategies.